With a COVID-19 vaccine coming onto the market, the need to revise South Africa’s outdated patent laws has never been greater.
Every vaccine bought for the UK has been on the assumption that just 30 million people - less than half the population - will get it.
Australia is in the grip of a drug crisis involving prescription medication.
Drug giants could quit the UK unless the NHS gets more funding.
According to a December report in the New England Journal of Medicine, a twin-pack of Evzio, which cost $690 just over two years ago, costs $4500 today.